Effectiveness of UrDiaCare (UrDiaCare)
Effectiveness of UrDiaCare: A Knowledge-Grounded Urdu Large Language Diabetes Management Application on Glycaemic Control Self Management Among Adults With Type 2 Diabetes in Pakistan: A Randomised Controlled Trial
The goal of this clinical trial is to learn if UrDiaCare, an Urdu-language diabetes support tool, can help adults with type 2 diabetes manage their Diabetes and improve blood sugar levels. The study will include adults aged 30 to 70 years with type 2 diabetes and higher-than-recommended blood sugar levels. The main question is whether UrDiaCare can lower HbA1c, a blood test that shows average blood sugar levels over the past few months, after four months.
Researchers will compare UrDiaCare plus standard diabetes care with standard diabetes care plus a single Urdu educational pamphlet. UrDiaCare provides diabetes self-management education and support through WhatsApp/Android. It uses a fixed, health-professional-reviewed information library and does not provide diagnosis or prescribe treatment.
調査の概要
詳細な説明
This study evaluates UrDiaCare, an Urdu-language, knowledge-grounded conversational assistant developed to support diabetes self-management among adults with type 2 diabetes in Pakistan. The intervention is designed to complement routine diabetes care by providing accessible, culturally appropriate education and ongoing support through WhatsApp.
UrDiaCare focuses on five areas of diabetes self-management: medication adherence, healthy eating, physical activity, blood glucose monitoring, and prevention of diabetes-related complications. Its development includes translating and culturally adapting diabetes education materials, expert review, and pilot testing with adults with type 2 diabetes to assess clarity, usability, cultural appropriateness, and technical functionality before finalizing the intervention.
The intervention is guided by Social Cognitive Theory (SCT) and the Health Belief Model (HBM). SCT emphasizes self-efficacy and supports mastery experiences, encouragement, and contextualized feedback. HBM informs messages addressing perceived susceptibility, severity, benefits, and barriers related to diabetes self-management. The conceptual framework proposes that UrDiaCare may improve self-efficacy and health beliefs, leading to better medication adherence and self-care behaviors and, ultimately, improved glycemic control.
UrDiaCare uses a knowledge-grounded, retrieval-augmented approach. Its responses are restricted to a predefined, clinician-reviewed knowledge library based on established diabetes education resources. The system is not a diagnostic or prescribing tool and does not provide individualized medical recommendations. Questions outside its approved educational scope trigger a standard response directing participants to their treating physician or an appropriate health facility. The knowledge library and safety rules are version-locked during the trial to maintain consistency.
The trial will use a parallel-group randomized controlled design. Participants will receive either UrDiaCare in addition to standard outpatient diabetes care or standard care with a static Urdu educational pamphlet covering the same five self-management areas. The study will follow participants for four months, with assessments conducted at baseline, two months, and four months.
The primary outcome is change in HbA1c from baseline to four months. Secondary outcomes assess medication adherence, diabetes self-management behavior, diabetes self-efficacy, self-care behaviors, and the usability and acceptability of UrDiaCare. The study will also examine factors associated with glycemic improvement among participants receiving UrDiaCare.
Intervention engagement and technical performance will be monitored throughout the study. UrDiaCare will use predefined safety checks to identify emergency or out-of-scope requests, while system information will be used to assess engagement and intervention delivery. Participant confidentiality will be protected through secure data-handling procedures, with identifying information and communication records stored separately and access restricted to authorized study personnel.
Overall, the study will determine whether adding a theory-informed, Urdu-language, knowledge-grounded conversational intervention to standard diabetes care can improve glycemic control and diabetes self-management. It will also provide evidence on the usability and safe implementation of an AI-assisted approach to diabetes self-management in Pakistan.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前：Shamaila Mohsin, P.hD in Public Health
- 電話番号：+92- 301-8219989
- メール：sm104177@hotmail.com
研究場所
-
-
Punjab Province
-
Gujranwala、Punjab Province、パキスタン、52250
- District Headquarter Hospital
-
-
参加基準
適格基準
就学可能な年齢
- 大人
- 高齢者
健康ボランティアの受け入れ
説明
Inclusion Criteria:
Adults aged 30-70 years with T2DM confirmed ≥ 6 months (clinical record) and HbA1c ≥ 7.5% at screening
- Currently prescribed oral antidiabetic medication(s) for ≥ 3 months
- Personal ownership and regular daily use of a functioning smartphone (Android/iOS)
- Able to read and understand Urdu
- Available for the full 4-month study period and willing to provide written informed consent -
Exclusion Criteria:
Type 1, gestational, or secondary diabetes (e.g., steroid-induced, MODY)
- Current insulin therapy (to avoid confounding from differing self-management complexity)
- Severe, uncorrectable comorbidity likely to materially affect glycemic control or survival within 4 months (e.g., end-stage renal disease, active malignancy, liver failure)
- Significant cognitive impairment or psychiatric disorder precluding informed consent or technology use
- Participation in another diabetes clinical trial within the preceding 3 months
- Insufficient Urdu reading proficiency, as the UrDiaCare interface is Urdu-script based
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：支持療法
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：UrDiaCare
Participants randomized to this arm will receive UrDiaCare, a knowledge-grounded retrieval-augmented generation (RAG) Urdu large language model self-management assistant, delivered via WhatsApp/Android for 4 months in addition to standard outpatient diabetes care.
UrDiaCare provides interactive Urdu diabetes self-management education and support covering glucose monitoring, medication management, diet, physical activity, and foot care.
The system uses a predefined, clinician-reviewed knowledge base and provides scope-limited educational responses.
|
UrDiaCare is a knowledge-grounded, retrieval-augmented generation (RAG)-based Urdu large language model self-management application delivered through WhatsApp/Android.
It provides interactive Urdu diabetes self-management education and support for 4 months in addition to standard outpatient diabetes care.
The intervention covers glucose monitoring, medication management, diet, physical activity, and foot care.
UrDiaCare uses a predefined, clinician-reviewed, version-locked knowledge library and a safety-scope check.
The system provides structured educational responses and scope-limited replies, and redirects out-of-scope requests requiring individualized clinical advice to the participant's treating physician or appropriate health facility.
|
|
アクティブコンパレータ：Urdu Educational Pamphlet
Participants randomized to this arm will receive standard outpatient diabetes care plus a single, non-interactive Urdu educational pamphlet delivered once at baseline via WhatsApp.
The pamphlet covers the same five diabetes self-management domains as the UrDiaCare content library: glucose monitoring, medication management, diet, physical activity, and foot care.
The pamphlet is static and does not provide interactive or ongoing conversational support.
|
Participants will receive standard outpatient diabetes care plus a single, non-interactive Urdu educational pamphlet delivered online via WhatsApp at baseline.
The pamphlet provides general diabetes self-management education covering five domains: blood glucose monitoring, medication adherence, healthy eating, physical activity, and foot care.
It does not provide interactive, personalized, or ongoing support.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in HbA1c (%) from baseline to 4 months
時間枠：Baseline to 4 Months
|
Glycated hemoglobin (HbA1c) will be measured as an indicator of glycemic control at baseline and at 4 months.
The primary analysis will compare the change in HbA1c from baseline to 4 months between the Urdiacare mHealth chatbot intervention group and the control group.
|
Baseline to 4 Months
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change in Diabetes Self-Management Questionnaire (DSMQ) score from baseline to 4 months
時間枠：Baseline, 2 months, and 4 months after randomization
|
The Diabetes Self-Management Questionnaire (DSMQ) will be used to assess diabetes self-management behaviors.
The total DSMQ score will be measured at baseline, 2 months, and 4 months.
Changes in scores over time will be compared between the intervention and control groups
|
Baseline, 2 months, and 4 months after randomization
|
|
Change in Urdu Diabetes Self-Efficacy Scale (U-DSES) score
時間枠：Baseline and 4 months after randomization
|
The Urdu Diabetes Self-Efficacy Scale (U-DSES) will be used to assess participants' confidence in managing their diabetes.
The total self-efficacy score will be assessed at baseline and at 4 months, and the change in score will be compared between the intervention and control groups.
|
Baseline and 4 months after randomization
|
|
Change in Urdu Summary of Diabetes Self-Care Activities (U-SDSCA) score
時間枠：Baseline, 2 months, and 4 months after randomization
|
The Urdu Summary of Diabetes Self-Care Activities (U-SDSCA) will be used to assess diabetes self-care behaviors, including dietary practices, physical activity, blood glucose testing, medication adherence, and foot care.
The score will be assessed at baseline, 2 months, and 4 months, and changes over time will be compared between the intervention and control groups.
|
Baseline, 2 months, and 4 months after randomization
|
協力者と研究者
出版物と役立つリンク
便利なリンク
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。